Sinopharm Group Co (SHTDF) Stock Forecast & Price Target

Compare

57 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

SHTDF Analyst Ratings

Moderate Buy

8 Buy

0 Hold

2 Sell

Based on 10 analysts giving stock ratings to

Sinopharm

Group Co

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

SHTDF Stock 12 Month Forecast

Average Price Target

$2.81

▲(9.77% Upside)

Based on 10 Wall Street analysts offering 12 month price targets for Sinopharm Group Co in the last 3 months. The average price target is $2.81 with a high forecast of $3.18 and a low forecast of $2.23. The average price target represents a 9.77% change from the last price of $2.56.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1":"$1","4":"$4","1.75":"$1.75","2.5":"$2.5","3.25":"$3.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":3.1768646,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$3.18</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2.81,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$2.81</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2.2250914,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$2.23</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1,1.75,2.5,3.25,4],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Mar<br/>2025","9":"Jun<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.25,2.321297276923077,2.3925945538461537,2.4638918307692306,2.535189107692308,2.6064863846153847,2.6777836615384616,2.7490809384615384,2.8203782153846153,2.8916754923076926,2.9629727692307695,3.0342700461538463,3.105567323076923,{"y":3.1768646,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.25,2.293076923076923,2.336153846153846,2.3792307692307695,2.4223076923076925,2.4653846153846155,2.5084615384615385,2.5515384615384615,2.5946153846153845,2.6376923076923076,2.680769230769231,2.723846153846154,2.766923076923077,{"y":2.81,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.25,2.248083953846154,2.246167907692308,2.2442518615384617,2.2423358153846156,2.2404197692307695,2.2385037230769234,2.236587676923077,2.2346716307692307,2.2327555846153846,2.2308395384615385,2.2289234923076924,2.2270074461538463,{"y":2.2250914,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":2.49,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.54,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.25,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.56,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.54,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.53,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.42,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.35,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.25,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.09,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.41,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.42,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.25,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$3.18

Average Price Target$2.81

Lowest Price Target$2.23

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Unknown Analyst

UBS

Not Ranked

UBS

$3.11

Buy

21.58%

Upside

Reiterated

10/27/25

Unknown Analyst

Daiwa

Not Ranked

Daiwa

$2.7

Buy

5.51%

Upside

Reiterated

10/27/25

Owen Mediport

TR | OpenAI - 4o

$2.64→$2.7

Buy

5.51%

Upside

Reiterated

10/21/25

AI Generated ArticleAI Generated Article

Unknown Analyst

First Shanghai Securities

Not Ranked

First Shanghai Securities

$2.74

Buy

7.01%

Upside

Reiterated

09/26/25

Unknown Analyst

HSBC

Not Ranked

HSBC

$2.32

Sell

-9.57%

Downside

Reiterated

09/12/25

Unknown Analyst

CICC

Not Ranked

CICC

$3.18

Buy

24.10%

Upside

Reiterated

08/27/25

Unknown Analyst

UBS

Not Ranked

UBS

$3.11

Buy

21.58%

Upside

Reiterated

08/26/25

Unknown Analyst

China Renaissance

Not Ranked

China Renaissance

$3.04

Buy

18.57%

Upside

Reiterated

08/26/25

Unknown Analyst

UOB Kay Hian

Not Ranked

UOB Kay Hian

$2.23

Sell

-13.08%

Downside

Reiterated

08/26/25

Unknown Analyst

Citi

Not Ranked

Citi

$2.92

Buy

14.05%

Upside

Reiterated

08/26/25

Unknown Analyst

Bank of America Securities

Not Ranked

Bank of America Securities

$2.96

Buy

15.56%

Upside

Reiterated

08/25/25

Laurence Tam

Morgan Stanley

$2.89

Buy

13.04%

Upside

Reiterated

08/22/25

Resilient Business Model and Strategic Financial Management Drive Buy Rating for Sinopharm Group

Unknown Analyst

Citic Securities

Not Ranked

Citic Securities

$2.83

Buy

10.53%

Upside

Reiterated

06/16/25

Unknown Analyst

Huatai Securities

Not Ranked

Huatai Securities

$2.9

Buy

13.24%

Upside

Reiterated

04/02/25

Unknown Analyst

First Shanghai Securities

Not Ranked

First Shanghai Securities

$3.08

Buy

20.28%

Upside

Reiterated

03/28/25

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Unknown Analyst

UBS

Not Ranked

UBS

$3.11

Buy

21.58%

Upside

Reiterated

10/27/25

Unknown Analyst

Daiwa

Not Ranked

Daiwa

$2.7

Buy

5.51%

Upside

Reiterated

10/27/25

Owen Mediport

TR | OpenAI - 4o

$2.64→$2.7

Buy

5.51%

Upside

Reiterated

10/21/25

AI Generated ArticleAI Generated Article

Unknown Analyst

First Shanghai Securities

Not Ranked

First Shanghai Securities

$2.74

Buy

7.01%

Upside

Reiterated

09/26/25

Unknown Analyst

HSBC

Not Ranked

HSBC

$2.32

Sell

-9.57%

Downside

Reiterated

09/12/25

Unknown Analyst

CICC

Not Ranked

CICC

$3.18

Buy

24.10%

Upside

Reiterated

08/27/25

Unknown Analyst

UBS

Not Ranked

UBS

$3.11

Buy

21.58%

Upside

Reiterated

08/26/25

Unknown Analyst

China Renaissance

Not Ranked

China Renaissance

$3.04

Buy

18.57%

Upside

Reiterated

08/26/25

Unknown Analyst

UOB Kay Hian

Not Ranked

UOB Kay Hian

$2.23

Sell

-13.08%

Downside

Reiterated

08/26/25

Unknown Analyst

Citi

Not Ranked

Citi

$2.92

Buy

14.05%

Upside

Reiterated

08/26/25

Unknown Analyst

Bank of America Securities

Not Ranked

Bank of America Securities

$2.96

Buy

15.56%

Upside

Reiterated

08/25/25

Laurence Tam

Morgan Stanley

$2.89

Buy

13.04%

Upside

Reiterated

08/22/25

Resilient Business Model and Strategic Financial Management Drive Buy Rating for Sinopharm Group

Unknown Analyst

Citic Securities

Not Ranked

Citic Securities

$2.83

Buy

10.53%

Upside

Reiterated

06/16/25

Unknown Analyst

Huatai Securities

Not Ranked

Huatai Securities

$2.9

Buy

13.24%

Upside

Reiterated

04/02/25

Unknown Analyst

First Shanghai Securities

Not Ranked

First Shanghai Securities

$3.08

Buy

20.28%

Upside

Reiterated

03/28/25

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Sinopharm Group Co

1 Month

xxx

Success Rate

2/4 ratings generated profit

Average Return

+1.13%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of +1.13% per trade.

3 Months

xxx

Success Rate

4/4 ratings generated profit

Average Return

+10.40%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +10.40% per trade.

1 Year

Laurence TamMorgan Stanley

Success Rate

3/4 ratings generated profit

Average Return

+4.05%

reiterated a buy rating 3 months ago

Copying Laurence Tam's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +4.05% per trade.

2 Years

xxx

Success Rate

4/4 ratings generated profit

Average Return

+10.08%

reiterated a xxx

rating 3 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +10.08% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SHTDF Analyst Recommendation Trends

Rating

May 25

Jun 25

Aug 25

Sep 25

Oct 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, SHTDF has received 16 Buy Ratings, 2 Hold Ratings, and 2 Sell Ratings. SHTDF average Analyst price target in the past 3 months is 2.81.

Each month's total comprises the sum of three months' worth of ratings.

SHTDF Financial Forecast

SHTDF Earnings Forecast

Next quarter’s earnings estimate for SHTDF is $0.16 with a range of $0.16 to $0.16. The previous quarter’s EPS was $0.08. SHTDF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year SHTDF has Preformed in-line its overall industry.

SHTDF Sales Forecast

Next quarter’s sales forecast for SHTDF is $39.87B with a range of $39.87B to $39.87B. The previous quarter’s sales results were ―. SHTDF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year SHTDF has Preformed in-line its overall industry.

SHTDF Stock Forecast FAQ

What is SHTDF’s average 12-month price target, according to analysts?

Based on analyst ratings, Sinopharm Group Co Ltd Class H’s 12-month average price target is 2.81.

What is SHTDF’s upside potential, based on the analysts’ average price target?

Sinopharm Group Co Ltd Class H has 9.77% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is SHTDF a Buy, Sell or Hold?

Sinopharm Group Co Ltd Class H has a consensus rating of Moderate Buy which is based on 8 buy ratings, 0 hold ratings and 2 sell ratings.

What is Sinopharm Group Co Ltd Class H’s price target?

The average price target for Sinopharm Group Co Ltd Class H is 2.81. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $3.18 ,the lowest forecast is $2.23. The average price target represents 9.77% Increase from the current price of $2.56.

What do analysts say about Sinopharm Group Co Ltd Class H?

Sinopharm Group Co Ltd Class H’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 10 Wall Streets Analysts.

How can I buy shares of SHTDF?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Sinopharm Group Co (SHTDF) Stock Forecast & Price Target

SHTDF Analyst Ratings

SHTDF Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Sinopharm Group Co

SHTDF Analyst Recommendation Trends

SHTDF Financial Forecast

SHTDF Earnings Forecast

SHTDF Sales Forecast

SHTDF Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts